Intracardial embryonic delivery of developmental modifiers in utero

Cold Spring Harbor Protocols

Volumn 7, Issue 9, 2012, Pages 962-968

  Domínguez Bendala, Juan ^a   Álvarez Cubela, Silvia ^a   Nieto, Margarita ^a   Vargas, Nancy ^a   Espino Grosso, Pedro ^a   Sacher, Vikas Y ^a   Pileggi, Antonello ^a   García, Enrique ^a   Ricordi, Camillo ^a   Inverardi, Luca ^a   Pastori, Ricardo L ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; GLUCAGON; GLUCOSE TRANSPORTER 2; INSULIN; MICRORNA; MICRORNA 7; MORPHOLINO OLIGONUCLEOTIDE; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR MAFA; UNCLASSIFIED DRUG; PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL STRUCTURE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DOPPLER FLOWMETRY; ECHOGRAPHY; EMBRYO; EMBRYO RESORPTION; FEMALE; HEART BEAT; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IN UTERO DELIVERY SYSTEM; MOLECULAR BIOLOGY; MOUSE; MOUSE EMBRYO; NONHUMAN; PANCREAS ISLET CELL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; ANIMAL; DEVELOPMENTAL BIOLOGY; DRUG EFFECT; HEART; INJECTION; METHODOLOGY; PRENATAL DEVELOPMENT;

MURINAE;

ANIMALS; DEVELOPMENTAL BIOLOGY; HEART; INJECTIONS; MICE; MORPHOLINOS; PROTEINS;

EID: 84865961366     PISSN: 19403402     EISSN: 15596095     Source Type: Journal    
DOI: 10.1101/pdb.prot069427     Document Type: Article

References (28)

1. Angerer LM, Angerer RC. 2004. Disruption of gene function using antisense morpholinos. Methods Cell Biol 74: 699-711.
2. Capecchi MR. 1989a. Altering the genome by homologous recombination. Science 244: 1288-1292.
3. Capecchi MR. 1989b. The new mouse genetics: altering the genome by gene targeting. Trends Genet 5: 70-76.
4. Carroll D. 2011. Genome engineering with zinc-finger nucleases. Genetics 188: 773-782.
5. Console S, Marty C, Garcia-Echeverria C, Schwendener R, Ballmer-Hofer K. 2003. Antennapedia and HIV transactivator of transcription (TAT) "protein transduction domains" promote endocytosis of high molecular weight cargo upon binding to cell surface glycosaminoglycans. J Biol Chem 278: 35109-35114.
6. Del Gaizo V, Payne RM. 2003. A novel TAT-mitochondrial signal sequence fusion protein is processed, stays in mitochondria, and crosses the placenta. Mol Ther 7: 720-730.
7. Domínguez-Bendala J, Klein D, Ribeiro M, Ricordi C, Inverardi L, Pastori R, Edlund H. 2005. TAT-mediated neurogenin 3 protein transduction stimulates pancreatic endocrine differentiation in vitro. Diabetes 54: 720-726.
8. Domínguez-Bendala J, Ricordi C, Pastori R. 2006. Protein transduction: a novel approach to induce in vitro pancreatic differentiation. Cell Transplantation 15: 85-90.
9. Gama Sosa MA, De Gasperi R, Elder GA. 2010. Animal transgenesis: an overview. Brain Struct Funct 214: 91-109.
10. Gordon JW, Ruddle FH. 1981. Integration and stable germ line transmission of genes injected into mouse pronuclei. Science 214: 1244-1246.
11. Gordon JW, Scangos GA, Plotkin DJ, Barbosa JA, Ruddle FH. 1980. Genetic transformation of mouse embryos by microinjection of purified DNA. Proc Natl Acad Sci 77: 7380-7384.
12. Hitz C, Steuber-Buchberger P, Delic S, Wurst W, Kuhn R. 2009. Generation of shRNA transgenic mice. Methods Mol Biol 530: 101-129.
13. Jensen J, Pedersen EE, Galante P, Hald J, Heller RS, Ishibashi M, Kageyama R, Guillemot F, Serup P, Madsen OD. 2000. Control of endodermal endocrine development by Hes-1. Nat Genet 24: 36-44.
14. Kaplan IM, Wadia JS, Dowdy SF. 2005. Cationic TAT peptide transduction domain enters cells by macropinocytosis. J Control Release 102: 247-253.
15. Kloosterman WP, Lagendijk AK, Ketting RF, Moulton JD, Plasterk RH. 2007. Targeted inhibition of miRNA maturation with morpholinos reveals a role for miR-375 in pancreatic islet development. PLoS Biol 5: e203.
16. Liu A, Joyner AL, Turnbull DH. 1998. Alteration of limb and brain patterning in early mouse embryos by ultrasound-guided injection of Shhexpressing cells. Mech Dev 75: 107-115.
17. Moulton JD, Jiang S. 2009. Gene knockdowns in adult animals: PPMOs and vivo-morpholinos. Molecules 14: 1304-1323.
18. Nieto M, Hevia P, Garcia E, Klein D, Alvarez-Cubela S, Bravo-Egana V, Rosero S, Molano RD, Vargas N, Ricordi C, et al. 2011. Antisense miR-7 impairs insulin expression in developing pancreas and in cultured pancreatic buds. Cell Transplant (in press).
19. Pastori RL, Klein D, Ribeiro MM, Ricordi C. 2004. Delivery of proteins and peptides into live cells by means of protein transduction domains: potential application to organ and cell transplantation. Transplantation 77: 1627-1631.
20. Porteus MH, Carroll D. 2005. Gene targeting using zinc finger nucleases. Nat Biotechnol 23: 967-973.
21. Punzo C, Cepko CL. 2008. Ultrasound-guided in utero injections allow studies of the development and function of the eye. Dev Dyn 237: 1034-1042.
22. Reissner KJ, Sartor GC, Vazey EM, Dunn TE, Aston-Jones G, Kalivas PW. 2012. Use of vivo-morpholinos for control of protein expression in the adult rat brain. J Neurosci Methods 203: 354-360.
23. Richard JP, Melikov K, Brooks H, Prevot P, Lebleu B, Chernomordik LV. 2005. Cellular uptake of unconjugated TAT peptide involves clathrindependent endocytosis and heparan sulfate receptors. J Biol Chem 280: 15300-15306.
24. Strasburger JF, Wakai RT. 2010. Fetal cardiac arrhythmia detection and in utero therapy. Nat Rev Cardiol 7: 277-290.
25. Tyagi M, Rusnati M, Presta M, Giacca M. 2001. Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans. J Biol Chem 276: 3254-3261.
26. Vargas N, Alvarez-Cubela S, Giraldo JA, Nieto M, Fort NM, Cechin S, Garcia E, Espino-Grosso P, Fraker CA, Ricordi C, et al. 2011. TAT-mediated transduction of MafA protein in utero results in enhanced pancreatic insulin expression and changes in islet morphology. PLoS One 6: e22364.
27. Wadia JS, Dowdy SF. 2002. Protein transduction technology. Curr Opin Biotechnol 13: 52-56.
28. Wadia JS, Dowdy SF. 2003. Modulation of cellular function by TAT mediated transduction of full-length proteins. Curr Protein Pept Sci 4: 97-104.